ritonavir has been researched along with naloxegol* in 1 studies
1 other study(ies) available for ritonavir and naloxegol
Article | Year |
---|---|
Molecular dynamics analysis predicts ritonavir and naloxegol strongly block the SARS-CoV-2 spike protein-hACE2 binding.
The rapid emergence of COVID-19 pandemics has posed humans particularly vulnerable to the novel SARS-CoV-2 virus. Since Topics: COVID-19 Drug Treatment; Humans; Molecular Dynamics Simulation; Morphinans; Polyethylene Glycols; Protein Binding; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2022 |